van Laar T - Search Results

1

Attentional and perceptual impairments in Parkinson's disease with visual hallucinations.

Koerts J, Borg MA, Meppelink AM, Leenders KL, van Beilen M, van Laar T. Koerts J, et al. Among authors: van beilen m, van laar t. Parkinsonism Relat Disord. 2010 May;16(4):270-4. doi: 10.1016/j.parkreldis.2010.01.003. Epub 2010 Feb 13. Parkinsonism Relat Disord. 2010. PMID: 20153970

2

Visual object recognition and attention in Parkinson's disease patients with visual hallucinations.

Meppelink AM, Koerts J, Borg M, Leenders KL, van Laar T. Meppelink AM, et al. Among authors: van laar t. Mov Disord. 2008 Oct 15;23(13):1906-12. doi: 10.1002/mds.22270. Mov Disord. 2008. PMID: 18709671

3

Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease.

van Nuenen BF, Esselink RA, Munneke M, Speelman JD, van Laar T, Bloem BR. van Nuenen BF, et al. Among authors: van laar t. Mov Disord. 2008 Dec 15;23(16):2404-6. doi: 10.1002/mds.21986. Mov Disord. 2008. PMID: 18951532 Clinical Trial.

4

Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations.

van Laar T, Postma AG, Drent M. van Laar T, et al. Parkinsonism Relat Disord. 2010 Jan;16(1):71-2. doi: 10.1016/j.parkreldis.2009.05.006. Epub 2009 Jun 12. Parkinsonism Relat Disord. 2010. PMID: 19524477 Clinical Trial. No abstract available.

5

The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot study.

Geerligs L, Meppelink AM, Brouwer WH, van Laar T. Geerligs L, et al. Among authors: van laar t. Clin Neuropharmacol. 2009 Sep-Oct;32(5):266-8. doi: 10.1097/WNF.0b013e3181a6a92b. Clin Neuropharmacol. 2009. PMID: 19667979

6

Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.

Meppelink AM, de Jong BM, Renken R, Leenders KL, Cornelissen FW, van Laar T. Meppelink AM, et al. Among authors: van laar t. Brain. 2009 Nov;132(Pt 11):2980-93. doi: 10.1093/brain/awp223. Epub 2009 Sep 15. Brain. 2009. PMID: 19755518

7

Lasting visual hallucinations in visual deprivation; fMRI correlates and the influence of rTMS.

Meppelink AM, de Jong BM, van der Hoeven JH, van Laar T. Meppelink AM, et al. Among authors: van laar t, van der hoeven jh. J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1295-6. doi: 10.1136/jnnp.2009.183087. Epub 2010 Jun 14. J Neurol Neurosurg Psychiatry. 2010. PMID: 20547615 No abstract available.

8

Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations.

Meppelink AM, de Jong BM, Teune LK, van Laar T. Meppelink AM, et al. Among authors: van laar t. Mov Disord. 2011 Jan;26(1):142-7. doi: 10.1002/mds.23375. Epub 2010 Oct 4. Mov Disord. 2011. PMID: 20922809

9

Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease.

Meppelink AM, Nyman R, van Laar T, Drent M, Prins T, Leenders KL. Meppelink AM, et al. Among authors: van laar t. Mov Disord. 2011 Feb 1;26(2):331-4. doi: 10.1002/mds.23408. Epub 2010 Oct 19. Mov Disord. 2011. PMID: 20960486

10

SCOPA-cognition cutoff value for detection of Parkinson's disease dementia.

Verbaan D, Jeukens-Visser M, Van Laar T, van Rooden SM, Van Zwet EW, Marinus J, van Hilten JJ. Verbaan D, et al. Among authors: van zwet ew, van hilten jj, van laar t, van rooden sm. Mov Disord. 2011 Aug 15;26(10):1881-6. doi: 10.1002/mds.23750. Epub 2011 May 3. Mov Disord. 2011. PMID: 21542025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters